Group One Trading, L.P. Praxis Precision Medicines, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.87 - $1.71 $2,148 - $4,223	2,470 Added 1379.89%	2,649 $4,000
Q2 2023 Aug 09, 2023	SELL	$0.83 - $1.18 $31,134 - $44,262	-37,511 Reduced 99.53%	179 $0
Q1 2023 May 12, 2023	BUY	$0.8 - $4.98 $30,152 - $187,696	37,690 New	37,690 $30,000
Q3 2022 Nov 09, 2022	SELL	$2.5 - $37.95 $980 - $14,876	-392 Reduced 9.54%	3,716 $8,000
Q2 2022 Aug 11, 2022	BUY	$1.75 - $11.34 $6,648 - $43,080	3,799 Added 1229.45%	4,108 $10,000
Q1 2022 May 12, 2022	BUY	$10.21 - $20.29 $3,154 - $6,269	309 New	309 $3,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.26B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.